GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Samsrita Labs Ltd (BOM:539267) » Definitions » LT-Debt-to-Total-Asset

Samsrita Labs (BOM:539267) LT-Debt-to-Total-Asset : 0.00 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Samsrita Labs LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Samsrita Labs's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.00.

Samsrita Labs's long-term debt to total assets ratio stayed the same from Dec. 2023 (0.00) to Dec. 2024 (0.00).


Samsrita Labs LT-Debt-to-Total-Asset Historical Data

The historical data trend for Samsrita Labs's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsrita Labs LT-Debt-to-Total-Asset Chart

Samsrita Labs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Samsrita Labs Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Samsrita Labs LT-Debt-to-Total-Asset Calculation

Samsrita Labs's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (A: Mar. 2024 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2024 )/Total Assets (A: Mar. 2024 )
=0/155.514
=

Samsrita Labs's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )/Total Assets (Q: Dec. 2024 )
=0/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Samsrita Labs  (BOM:539267) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Samsrita Labs LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Samsrita Labs's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Samsrita Labs Business Description

Traded in Other Exchanges
N/A
Address
Suryateja Apartments, 6-3-354/13/B2, Flat No. B2, Hindinagar, Punjagutta, Hyderabad, TG, IND, 500082
Samsrita Labs Ltd is an India based diversified healthcare company. The company's operations include research and excellence in the areas of Stem cell research and development and therapy, New drug discovery, Diagnostics and Bio Lab, Pharmacy, Out-Patient Consultancy Division in name of ORIGIN HOSPITALS, and Research and Development in Biotechnology. It has one reportable segment namely, healthcare services including hospital, diagnostics, Pharma, and Biotechnology.

Samsrita Labs Headlines

No Headlines